<?xml version="1.0" encoding="UTF-8"?>
<ref id="B209-nutrients-13-00462">
 <label>209.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Brinton</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>Ballantyne</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Bays</surname>
    <given-names>H.E.</given-names>
   </name>
   <name>
    <surname>Kastelein</surname>
    <given-names>J.J.P.</given-names>
   </name>
   <name>
    <surname>Braeckman</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Soni</surname>
    <given-names>P.N.</given-names>
   </name>
  </person-group>
  <article-title>Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200â€“500 mg/dL), and on statin therapy at LDL-C goal: The ANCHOR study</article-title>
  <source>Cardiovasc. Diabetol.</source>
  <year>2013</year>
  <volume>12</volume>
  <fpage>1</fpage>
  <lpage>100</lpage>
  <pub-id pub-id-type="doi">10.1186/1475-2840-12-100</pub-id>
  <pub-id pub-id-type="pmid">23280391</pub-id>
 </element-citation>
</ref>
